Welcome to our dedicated page for INNOVATIVE EYEWEAR SEC filings (Ticker: LUCYW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Smart eyewear sounds simple until you open Innovative Eyewear’s latest 10-K and face pages of patent jargon, equity raises and segment data on Lucyd® and Nautica® frames. If you have ever asked, “How do I read Innovative Eyewear’s annual report 10-K simplified?” or “Where are those Innovative Eyewear insider trading Form 4 transactions?” you know the challenge.
Stock Titan solves it. Our platform delivers AI-powered summaries that turn dense disclosures into plain-English insight—highlighting R&D spend behind ChatGPT-enabled glasses, cash burn from manufacturing scale-up, and licensing revenue terms. Need the next Innovative Eyewear quarterly earnings report 10-Q filing? It arrives here the moment it hits EDGAR, complete with key metrics and trend visuals. Curious about a sudden executive sale? Get Innovative Eyewear Form 4 insider transactions real-time, including context on option grants and vesting.
Use this page to:
- Track every 8-K material event—new retail partnerships or patent wins—Innovative Eyewear 8-K material events explained.
- Compare quarter-over-quarter revenue through our Innovative Eyewear earnings report filing analysis.
- Review the proxy statement for detailed Innovative Eyewear executive compensation data.
- Monitor Innovative Eyewear executive stock transactions Form 4 before product launches.
Whether you’re an analyst measuring dilution risk, or a retail investor trying to understand Bluetooth component costs, our real-time feed and expert commentary keep every Innovative Eyewear SEC filing explained simply. Stop scrolling through PDFs—start understanding Innovative Eyewear SEC documents with AI in seconds.
Innovative Eyewear, Inc. (Nasdaq: LUCY / LUCYW) filed an 8-K disclosing a cash-for-warrant inducement completed on 20 June 2025. The company persuaded holders of 746,782 existing warrants (originally issued 14 Apr 2025, strike $2.60) to exercise in full. In exchange, the holders purchased—at $0.125 per warrant—2,240,346 new Series I warrants ("New Warrants") that carry the same $2.60 exercise price, are immediately exercisable and expire 18 months after the related resale registration statement becomes effective.
Gross proceeds total approximately $2.2 million (≈ $1.94 million from warrant exercise plus ≈ $0.28 million from New Warrant purchase). Net proceeds will be lower after:
- Placement agent cash fee: 7.5 % of gross
- Management fee: 1.0 % of gross
- Expenses: $90,950 (accountable, non-accountable and clearing)
Placement agent H.C. Wainwright & Co. also received:
- 56,009 PA Warrants (strike $3.25, 18-month term)
- 73,990 Ordinary-Course PA Warrants (strike $3.25, expire 20 Jun 2030)
The company must file a resale registration statement for the New Warrant shares within 30 days and seek SEC effectiveness within 60 days (90 days if fully reviewed). It agreed to:
- Refrain from issuing or registering additional equity for 30 days
- Avoid variable-rate transactions for one year (limited exception)
Use of proceeds: working capital and general corporate purposes.
Capital structure impact: Immediately adds 746,782 common shares; a further 2,240,346 shares (plus 130,000+ PA-related shares) could enter the float if all new warrants are exercised, creating a sizeable potential dilution relative to the modest cash infusion.